NCT04829604 2026-03-09ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)Ambrx, Inc.Phase 2 Active not recruiting72 enrolled
NCT06014658 2026-03-02Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid TumorsMBrace TherapeuticsPhase 1/2 Recruiting130 enrolled
NCT07052760 2025-10-10Imaging of Solid Tumors Using DLL3 SPECTUniversity of California, San FranciscoPhase EARLY_PHASE1 Not yet recruiting45 enrolled
NCT05011188 2025-08-27FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate CancerUniversity of California, San FranciscoPhase 1/2 Active not recruiting44 enrolled